RSMD.F Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.75 |
| 52 Week High | US$22.75 |
| 52 Week Low | US$16.24 |
| Beta | 0.69 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 43.81% |
| 33 Year Change | -8.78% |
| 5 Year Change | 59.65% |
| Change since IPO | 732.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSMD.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | n/a | -0.4% | -1.0% |
| 1Y | 43.8% | 20.3% | 30.3% |
Return vs Industry: RSMD.F exceeded the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: RSMD.F exceeded the US Market which returned 30.4% over the past year.
Price Volatility
| RSMD.F volatility | |
|---|---|
| RSMD.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RSMD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RSMD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
| RSMD.F fundamental statistics | |
|---|---|
| Market cap | US$34.94b |
| Earnings (TTM) | US$1.11b |
| Revenue (TTM) | US$4.81b |
31.9x
P/E Ratio7.4x
P/S RatioIs RSMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSMD.F income statement (TTM) | |
|---|---|
| Revenue | US$4.81b |
| Cost of Revenue | US$2.00b |
| Gross Profit | US$2.80b |
| Other Expenses | US$1.69b |
| Earnings | US$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 58.33% |
| Net Profit Margin | 23.15% |
| Debt/Equity Ratio | 13.0% |
How did RSMD.F perform over the long term?
See historical performance and comparison